Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Companion diagnostics

Diagnostics Companion diagnostics

Collaborating Early to Advance Precision Medicine

| Sponsored by Thermo Fisher Scientific | 7 min read

How companion diagnostic tests are helping cancer patients find personalized answers – and treatments – fast

Diagnostics Analytical science

User experience of the Ion Torrent™ Genexus™ Integrated Sequencer

| Sponsored by Thermo Scientific

Users share their experiences with the Ion Torrent™ Genexus™ platform over the two years since the technology was introduced to the lab community

Diagnostics Companion diagnostics

Atezolizumab Assay Angst

| David Rimm

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

Diagnostics Companion diagnostics

Which Assay for Atezolizumab?

| Emina Torlakovic, Allen M. Gown

Emina Torlakovic and Allen Gown share their disagreements with David Rimm’s comments about an FDA-approved PD-L1 assay for atezolizumab

Diagnostics Companion diagnostics

What Would Your Oncologist Think If…

| Roberto Salgado

Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?

Diagnostics Companion diagnostics

Improving Patient Outcomes

| Eslie Dennis, Eric Walk, Ken Bloom, Mark Kockx

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

Diagnostics Companion diagnostics

Welcome to Our Kitchen

| David L. Rimm

David Rimm challenges the sensitivity and reproducibility of a new assay for PD-L1 detection.

Inside the Lab Companion diagnostics

Fluid Evidence

Liquid biopsy can help us appropriately treat patients with anti-PD-L1 immunotherapies, and ddPCR enables ongoing monitoring and adjustment of treatment

Subspecialties Biochemistry and molecular biology

A Boost for Cervical Cancer Screening

| Liang Cao, Zhigang Kang

An efficient alternative to pap-HPV tests could lie with ddPCR and a ccfDNA assay

Inside the Lab Genetics and epigenetics

A Guiding Light for Molecular Testing

| Antonia R. Sepulveda

New collaborative guidelines for molecular biomarker testing in colorectal cancer


Latest Application Notes

The next generation of advanced staining

| Contributed by Sakura

All Application Notes

Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register